spacer
spacer

PDBsum entry 4gux

Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Hydrolase/hydrolase inhibitor PDB id
4gux

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
223 a.a.
34 a.a.
Ligands
ACT ×2
Metals
_CA ×3
Waters ×1225
PDB id:
4gux
Name: Hydrolase/hydrolase inhibitor
Title: Crystal structure of trypsin:mcoti-ii complex
Structure: Cationic trypsin. Chain: a, b, c. Synonym: beta-trypsin, alpha-trypsin chain 1, alpha-trypsin chain 2. Trypsin inhibitor 2. Chain: d, e, f. Synonym: mcoti-ii, trypsin inhibitor ii
Source: Bos taurus. Bovine,cow,domestic cattle,domestic cow. Organism_taxid: 9913. Momordica cochinchinensis. Spiny bitter cucumber. Organism_taxid: 3674
Resolution:
1.80Å     R-factor:   0.162     R-free:   0.194
Authors: G.J.King,N.L.Daly,L.Thorstholm,K.P.Greenwood,K.J.Rosengren,B.Heras, D.J.Craik,J.L.Martin
Key ref: N.L.Daly et al. (2013). Structural insights into the role of the cyclic backbone in a squash trypsin inhibitor. J Biol Chem, 288, 36141-36148. PubMed id: 24169696 DOI: 10.1074/jbc.M113.528240
Date:
30-Aug-12     Release date:   04-Sep-13    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P00760  (TRY1_BOVIN) -  Serine protease 1 from Bos taurus
Seq:
Struc:
246 a.a.
223 a.a.
Protein chains
Pfam   ArchSchema ?
P82409  (ITR2_MOMCO) -  Trypsin inhibitor 2 from Momordica cochinchinensis
Seq:
Struc:
34 a.a.
34 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: Chains A, B, C: E.C.3.4.21.4  - trypsin.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Preferential cleavage: Arg-|-Xaa, Lys-|-Xaa.

 

 
DOI no: 10.1074/jbc.M113.528240 J Biol Chem 288:36141-36148 (2013)
PubMed id: 24169696  
 
 
Structural insights into the role of the cyclic backbone in a squash trypsin inhibitor.
N.L.Daly, L.Thorstholm, K.P.Greenwood, G.J.King, K.J.Rosengren, B.Heras, J.L.Martin, D.J.Craik.
 
  ABSTRACT  
 
MCoTI-II is a head-to-tail cyclic peptide with potent trypsin inhibitory activity and, on the basis of its exceptional proteolytic stability, is a valuable template for the design of novel drug leads. Insights into inhibitor dynamics and interactions with biological targets are critical for drug design studies, particularly for protease targets. Here, we show that the cyclization and active site loops of MCoTI-II are flexible in solution, but when bound to trypsin, the active site loop converges to a single well defined conformation. This finding of reduced flexibility on binding is in contrast to a recent study on the homologous peptide MCoTI-I, which suggested that regions of the peptide are more flexible upon binding to trypsin. We provide a possible explanation for this discrepancy based on degradation of the complex over time. Our study also unexpectedly shows that the cyclization loop, not present in acyclic homologues, facilitates potent trypsin inhibitory activity by engaging in direct binding interactions with trypsin.
 

 

spacer

spacer